Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 2/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.32 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.31 |
| ▸ | PPARG | P37231 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6077985 | 1.00 | F10 (0.38) | F10SLC1A2CACNA1GITGB3ITGA2B | |
| SCHEMBL6030857 | 0.99 | F10 (0.38) | F10SLC1A2CACNA1GITGB3ITGA2B | |
| SCHEMBL6030868 | 0.99 | F10 (0.38) | F10SLC1A2CACNA1GITGB3ITGA2B | |
| Acetic Acid SCHEMBL6079078 | 0.98 | F10 (0.38) | F10SLC1A2CACNA1GITGB3ITGA2B | |
| Acetic Acid SCHEMBL6076966 | 0.97 | F10 (0.38) | F10SLC1A2CACNA1GITGB3ITGA2B | |
| SCHEMBL6079576 | 0.90 | F10 (0.38) | F10ITGB3ITGA2BITGA2KLKB1 | |
| SCHEMBL6079587 | 0.90 | F10 (0.38) | F10ITGB3ITGA2BITGA2KLKB1 | |
| SCHEMBL6077932 | 0.90 | F10 (0.38) | F10ITGB3ITGA2BITGA2KLKB1 | |
| Hydrochloric Acid SCHEMBL6078149 | 0.90 | F10 (0.38) | F10ITGB3ITGA2BITGA2KLKB1 | |
| Hydrochloric Acid SCHEMBL6029994 | 0.90 | F10 (0.38) | F10ITGB3ITGA2BITGA2KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7056932-B2 | Heterocyclyl substituted 1-alkoxy acetic acid amides | HOFFMAN-LA ROCHE INC. (US) | 2006-06-06 | — | — | US | disclosed |
| US-20050137168-A1 | Heterocyclyl substituted 1-alkoxy acetic acid amides | HOFFMANN-LA ROCHE INC. | 2005-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050137168-A1 | Heterocyclyl substituted 1-alkoxy acetic acid amides | F12, TFPI, F11 | F10 8/4885SLC1A2 2506/4885CACNA1G 1711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.